Aldeyra Therapeutics Statistics
NASDAQ: ALDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.84+0.1183 (+16.39%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Aldeyra Therapeutics by the numbers
Aldeyra Therapeutics has a market capitalization of $50.7 million based on 60.36M shares outstanding. With trailing EPS of $-0.31, Aldeyra Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.2% below its 50-day average and 56.8% below its 200-day average.
Average daily trading volume is 1.16M shares, or about $972,303 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALDX valuation vs. peer median
| Metric | ALDX | Peer median | Difference |
|---|---|---|---|
| Market cap | $50.70M | $51.66M | -2% |
| Avg. volume | 1.16M | 114.54K | +911% |
Peer median across 8 companies: CLNN, ACRV, LFVN, XBIT, CTOR, HRTX, XLO, RFL.
Valuation
- Market cap
- $50.70M
- EPS (TTM)
- $-0.31
- Shares outstanding
- 60.36M
Price and trading
- Previous close
- 0.7217
- Open
- 0.69
- Day range
- 0.6589 – 0.8849
- 52-week range
- 0.527 – 5.93
- 52-week change
- -83.06%
- 50-day moving average
- 0.8953
- Beta
- —
- Volume
- 2.47M
- Average volume
- 1.16M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 50.70M
- Forward Pe
- -3.50
- Eps
- -0.31
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.93
- Week52 Low
- 0.53
- Avg Volume
- 1.16M
- Shares Outstanding
- 60.36M
- Ma50
- 0.90
- Ma200
- 1.94
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -85.83%
- Pct From52w Low
- 59.39%